List of bibliographic references
Number of relevant bibliographic references: 87.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (1999) |
J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin | A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease. |
| 000021 (1999) |
O. Rascol [France] | Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease? |
| 000028 (1999) |
O. Rascol [France] ; O. Blin ; C. Thalamas ; S. Descombes ; C. Soubrouillard ; P. Azulay ; N. Fabre ; F. Viallet ; K. Lafnitzegger ; S. Wright ; J H Carter ; J G Nutt | ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease. |
| 000036 (1999) |
O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc | Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients. |
| 000040 (1999) |
M B Delisle [France] ; J R Murrell ; R. Richardson ; J A Trofatter ; O. Rascol ; X. Soulages ; M. Mohr ; P. Calvas ; B. Ghetti | A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. |
| 000042 (1999) |
C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease. |
| 000047 (????) |
H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc | A study of salivary secretion in Parkinson's disease. |
| 000062 (1999) |
O. Rascol [France] | L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach. |
| 000064 (1999) |
J L Montastruc [France] ; O. Rascol ; J M Senard | Treatment of Parkinson's disease should begin with a dopamine agonist. |
| 000079 (1999) |
E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E Gross | Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. |
| 000116 (2000) |
O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E Lang | A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. |
| 000127 (2000) |
O. Rascol [France] ; J L Montastruc | [Role of dopaminergic agonists]. |
| 000132 (2000) |
J J Ferreira [France] ; O. Rascol | Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease. |
| 000137 (2000) |
O. Rascol [France] | The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease. |
| 000163 (2001) |
O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. Wright | Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. |
| 000182 (2001) |
S. Descombes [France] ; A M Bonnet ; U E Gasser ; C. Thalamas ; J. Dingemanse ; I. Arnulf ; M P Bareille ; Yves Agid [France] ; O. Rascol | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease. |
| 000183 (2001) |
O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc | The pharmacologic treatment of gait ignition failure. |
| 000189 (????) |
J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre | Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. |
| 000191 (2001) |
J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon | Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease. |
| 000200 (2001) |
O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. |
| 000201 (2001) |
J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L Montastruc | Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "O. Rascol"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i \
-Sk "O. Rascol" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= O. Rascol
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
